RANI THERAPEUTICS HOLDINGS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
RANI THERAPEUTICS HOLDINGS, INC. (RANI) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $2.42 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-13
- RANI THERAPEUTICS HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $2.42M, a 26.37% decline year-over-year.
- RANI THERAPEUTICS HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $2.08M, a 46.90% decline year-over-year.
- RANI THERAPEUTICS HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $2.34M, a 42.02% decline year-over-year.
- RANI THERAPEUTICS HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $3.29M, a 20.27% decline year-over-year.
- RANI THERAPEUTICS HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $11.80M, a 26.41% decline from fiscal 2024.
- RANI THERAPEUTICS HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $16.03M, a 15.72% decline from fiscal 2023.
- RANI THERAPEUTICS HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $19.02M, a 20.42% increase from fiscal 2022.
- RANI THERAPEUTICS HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $15.79M, a 8.83% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.42M 10-Q · filed 2026-08-13 | $4.51M derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $2.08M 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | $11.80M 10-K · filed 2026-03-26 | |||
| 2025-09-30 | $2.34M 10-Q · filed 2025-11-06 | $5.63M derived: sum of 2 quarters · filed 2026-08-13 | $9.56M derived: sum of 3 quarters · filed 2026-08-13 | |
| 2025-06-30 | $3.29M 10-Q · filed 2026-08-13 | $7.22M derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $3.92M 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $16.03M 10-K · filed 2026-03-26 | |||
| 2024-09-30 | $4.04M 10-Q · filed 2025-11-06 | $8.17M derived: sum of 2 quarters · filed 2025-11-06 | $12.04M derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $4.13M 10-Q · filed 2025-11-06 | $8.00M derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $3.87M 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $19.02M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $4.98M 10-Q · filed 2024-11-14 | $10.12M derived: sum of 2 quarters · filed 2024-11-14 | $14.53M derived: sum of 3 quarters · filed 2024-11-14 | |
| 2023-06-30 | $5.14M 10-Q · filed 2024-11-14 | $9.56M derived: sum of 2 quarters · filed 2024-11-14 | ||
| 2023-03-31 | $4.42M 10-Q · filed 2024-11-14 | |||
| 2022-12-31 | $15.79M 10-K · filed 2024-03-20 | |||
| 2022-09-30 | $4.41M 10-Q · filed 2023-11-08 | $8.39M derived: sum of 2 quarters · filed 2023-11-08 | $11.30M derived: sum of 3 quarters · filed 2023-11-08 | |
| 2022-06-30 | $3.98M 10-Q · filed 2023-11-08 | $6.89M derived: sum of 2 quarters · filed 2023-11-08 | ||
| 2022-03-31 | $2.90M 10-Q · filed 2023-11-08 | |||
| 2021-12-31 | $17.32M 10-K · filed 2023-03-22 | |||
| 2021-09-30 | $17.04M 10-Q · filed 2022-11-10 | $17.32M derived: sum of 2 quarters · filed 2022-11-10 | $17.78M derived: sum of 3 quarters · filed 2022-11-10 | |
| 2021-06-30 | $282.00K 10-Q · filed 2022-11-10 | $735.00K derived: sum of 2 quarters · filed 2022-11-10 | ||
| 2021-03-31 | $453.00K 10-Q · filed 2022-11-10 |